معرفی
Marlies Lourens is a Full Professor at Erasmus MC, Department of Pulmonary Medicine, where she leads research and clinical efforts in interstitial lung diseases, particularly idiopathic pulmonary fibrosis and sarcoidosis. Her work bridges clinical practice and translational research, with a focus on diagnosis, treatment, and innovative care models.
Her research interests center on Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Sarcoidosis. She investigates disease progression, treatment efficacy, and patient-centered outcomes, including symptom management and quality of life. Recently, she has explored machine learning applications to improve care pathways for sarcoidosis patients, highlighting her forward-thinking approach to respiratory medicine.
The recent articles reflect a strong clinical focus on progressive fibrotic lung diseases, with multiple publications in high-impact journals such as the New England Journal of Medicine and Respiratory Research. Themes include novel therapeutics (e.g., nerandomilast), comparative treatment strategies (e.g., prednisone vs. methotrexate), and international consensus on familial ILD. These works emphasize evidence-based medicine and collaborative, multi-center research.
While no specific awards are listed, her leadership in major clinical trials and consistent publication record indicate significant recognition in the field of pulmonary medicine.
Marlies Lourens supervises academic work, as indicated by six supervised items in her profile, suggesting active mentorship of junior researchers and clinicians. She has not disclosed grant details, but her role in large trials implies substantial research funding. Her research network spans multiple countries, reflecting international collaboration in ILD research.
She is involved in key research initiatives such as the FIBRONEER ILD Trial and contributes to editorial and peer-review activities, further establishing her as a leading figure in pulmonary medicine.
